Highest Price Target1
Lowest Price Target1
Consensus Price Target1
Analyst Rating Summary1
| Buy | Overweight | Hold | Underweight | Sell |
|---|---|---|---|---|
| 4 | 1 | 0 | 0 | 0 |
Analyst Firms Making Recommendations1
- HC Wainwright & Co.
- Jefferies
- Cowen & Co.
- Ladenburg Thalmann
- Piper Sandler
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Aadi Bioscience
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 11/13/2023 | AADI | Buy Now | Aadi Bioscience | $4.99 | 621.44% | HC Wainwright & Co. | Robert Burns | $45 → $36 | Maintains | Buy | Get Alert |
| 08/10/2023 | AADI | Buy Now | Aadi Bioscience | $4.99 | 801.8% | HC Wainwright & Co. | Robert Burns | → $45 | Reiterates | Buy → Buy | Get Alert |
| 06/08/2023 | AADI | Buy Now | Aadi Bioscience | $4.99 | 801.8% | HC Wainwright & Co. | Robert Burns | → $45 | Reiterates | Buy → Buy | Get Alert |
| 05/17/2023 | AADI | Buy Now | Aadi Bioscience | $4.99 | 801.8% | HC Wainwright & Co. | Robert Burns | → $45 | Reiterates | Buy → Buy | Get Alert |
| 03/29/2023 | AADI | Buy Now | Aadi Bioscience | $4.99 | 801.8% | HC Wainwright & Co. | Robert Burns | $48 → $45 | Maintains | Buy | Get Alert |
| 04/11/2022 | AADI | Buy Now | Aadi Bioscience | $4.99 | 861.92% | HC Wainwright & Co. | Robert Burns | $735 → $720 | Maintains | Buy | Get Alert |
| 01/11/2022 | AADI | Buy Now | Aadi Bioscience | $4.99 | 801.8% | Jefferies | Roger Song | → $675 | Initiates | → Buy | Get Alert |
| 11/24/2021 | AADI | Buy Now | Aadi Bioscience | $4.99 | 881.96% | HC Wainwright & Co. | Robert Burns | — | Maintains | Buy | Get Alert |
| 10/01/2021 | AADI | Buy Now | Aadi Bioscience | $4.99 | — | Cowen & Co. | Boris Peaker | — | Initiates | → Outperform | Get Alert |
| 09/14/2021 | AADI | Buy Now | Aadi Bioscience | $4.99 | 922.04% | Ladenburg Thalmann | — | — | Initiates | → Buy | Get Alert |
| 09/08/2021 | AADI | Buy Now | Aadi Bioscience | $4.99 | 801.8% | Piper Sandler | Joseph Catanzaro | — | Initiates | → Overweight | Get Alert |
| 08/30/2021 | AADI | Buy Now | Aadi Biosciences, Inc. - Common Stock | $4.99 | 841.88% | HC Wainwright & Co. | Robert Burns | — | Maintains | Buy | Get Alert |
What is the target price for Aadi Bioscience (AADI)?
The latest price target for Aadi Bioscience (NASDAQ: AADI) was reported by HC Wainwright & Co. on November 13, 2023. The analyst firm set a price target for $36.00 expecting AADI to rise to within 12 months (a possible 621.44% upside). 5 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Aadi Bioscience (AADI)?
The latest analyst rating for Aadi Bioscience (NASDAQ: AADI) was provided by HC Wainwright & Co., and Aadi Bioscience maintained their buy rating.
When is the next analyst rating going to be posted or updated for Aadi Bioscience (AADI)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Aadi Bioscience, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Aadi Bioscience was filed on November 13, 2023 so you should expect the next rating to be made available sometime around November 13, 2024.
Is the Analyst Rating Aadi Bioscience (AADI) correct?
While ratings are subjective and will change, the latest Aadi Bioscience (AADI) rating was a maintained with a price target of $45.00 to $36.00. The current price Aadi Bioscience (AADI) is trading at is $4.99, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.